dc.contributor.author |
Peirano, Gisele
|
|
dc.contributor.author |
Chen, Liang
|
|
dc.contributor.author |
Nobrega, Diego
|
|
dc.contributor.author |
Finn, Thomas J.
|
|
dc.date.accessioned |
2023-06-08T05:12:28Z |
|
dc.date.available |
2023-06-08T05:12:28Z |
|
dc.date.issued |
2022-05 |
|
dc.description.abstract |
We describe the global molecular epidemiology of 229 carbapenemase-producing Escherichia coli in 36 countries during 2015–2017. Common carbapenemases were oxacillinase (OXA) 181 (23%), New Delhi metallo-β-lactamase (NDM) 5 (20%), OXA-48 (17%), Klebsiella pneumoniae carbapenemase 2 (15%), and NDM-1 (10%). We identified 5 dominant sequence types (STs); 4 were global (ST410, ST131, ST167, and ST405), and 1 (ST1284) was limited to Turkey. OXA-181 was frequent in Jordan (because of the ST410-B4/H24RxC subclade) and Turkey (because of ST1284). We found nearly identical IncX3-blaOXA-181 plasmids among 11 STs from 12 countries. NDM-5 was frequent in Egypt, Thailand (linked with ST410-B4/H24RxC and ST167-B subclades), and Vietnam (because of ST448). OXA-48 was common in Turkey (linked with ST11260). Global K. pneumoniae carbapenemases were linked with ST131 C1/H30 subclade and NDM-1 with various STs. The global carbapenemase E. coli population is dominated by diverse STs with different characteristics and varied geographic distributions, requiring ongoing genomic surveillance. |
en_US |
dc.description.department |
Medical Microbiology |
en_US |
dc.description.librarian |
am2023 |
en_US |
dc.description.sponsorship |
The Joint Programming Initiative on Antimicrobial Resistance–Canadian Institute Health Research program and the US National Institutes of Health. |
en_US |
dc.description.uri |
http://wwwnc.cdc.gov/eid |
en_US |
dc.identifier.citation |
Peirano, G., Chen, L., Nobrega, D. et al. 2022, 'Genomic epidemiology of global carbapenemase-producing escherichia coli, 2015–2017', Emerging Infectious Diseases, vol. 28, no. 5, pp. 924-931, doi : 10.3201/eid2805.212535.
. |
en_US |
dc.identifier.issn |
1080-6040 (print) |
|
dc.identifier.issn |
1080-6059 (online) |
|
dc.identifier.other |
10.3201/eid2805.212535 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/91048 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Centers for Disease Control and Prevention |
en_US |
dc.rights |
© 2022, Centers for Disease Control and Prevention (CDC). All rights reserved. |
en_US |
dc.subject |
Surveillance |
en_US |
dc.subject |
Carbapenemases |
en_US |
dc.subject |
Molecular epidemiology |
en_US |
dc.subject |
Escherichia coli |
en_US |
dc.subject |
Bacteria |
en_US |
dc.subject |
Whole-genome sequencing (WGS) |
en_US |
dc.subject |
Antimicrobial resistance (AMR) |
en_US |
dc.title |
Genomic epidemiology of global carbapenemase-producing Escherichia coli, 2015–2017 |
en_US |
dc.type |
Article |
en_US |